Glucocorticoid therapy-induced skin atrophy (Q36475498)

14 August 2017

1 reference

title

Glucocorticoid therapy-induced skin atrophy (English)

1 reference

14 August 2017

Stefanie Schoepe

1

1 reference

14 August 2017

Heike Schäcke

series ordinal

2

1 reference

14 August 2017

Ekkehard May

series ordinal

3

1 reference

14 August 2017

Khusru Asadullah

series ordinal

4

1 reference

14 August 2017

1 June 2006

1 reference

14 August 2017

Experimental Dermatology

1 reference

14 August 2017

15

1 reference

14 August 2017

6

1 reference

14 August 2017

406-420

1 reference

Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Quantification of corticosteroid-induced skin vasoconstriction: visual ranking, chromameter measurement or digital imaging analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Modulation of Epidermal Terminal Differentiation in Patients after Long-term Topical Corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Glucocorticoids mediate differential anti-apoptotic effects in human fibroblasts and keratinocytes via sphingosine-1-phosphate formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

DNA regulatory elements for steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Allosteric effects of DNA on transcriptional regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Mechanisms involved in the side effects of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

New aspects of the mechanism of corticosteroid–induced dermal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Identification of novel glucocorticoid-response elements in human elastin promoter and demonstration of nucleotide sequence specificity of the receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Glucocorticoid regulation of elastin synthesis in human fibroblasts: down-regulation in fibroblasts from normal dermis but not from keloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Dermoscopic assessment of long-term topical therapies with potent steroids in chronic psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Effects of mometasone furoate on human keratinocytes and fibroblasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Effects of glucocorticosteroids on cultured human skin fibroblasts. III. Transient inhibition of cell proliferation in the early growth stages and reduced susceptibility in later growth stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Modulation of collagen synthesis and mRNA by continuous and intermittent use of topical hydrocortisone in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Maintenance treatment and early intervention--the new paradigm in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Different skin thinning potential of equipotent medium-strength glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

The role of intracellular esterification in budesonide once-daily dosing and airway selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Immune-inflammatory functions of fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Expression of pro-inflammatory markers by human dermal fibroblasts in a three-dimensional culture model is mediated by an autocrine interleukin-1 loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Improved risk-benefit ratio for topical triamcinolone acetonide in TransfersomeR in comparison with equipotent cream and ointment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Drug targeting by solid lipid nanoparticles for dermal use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Cytokine-directed therapies for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Optimised glucocorticoid therapy: the sharpening of an old spear

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

A fibroblast protein binds the 3'-untranslated region of pro-alpha 1(I) collagen mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Dexamethasone modulates the metabolism of type IV collagen and fibronectin in human basement-membrane-forming fibrosarcoma (HT-1080) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Comparison of the effects of dexamethasone and 13-cis-retinoic acid on connective tissue biosynthesis in human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00435.X

10.1111/J.0906-6705.2006.00435.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference